Summary
ImmuNext
Founded in 2011
Description
ImmuNext is a company that develops immune-based therapeutics to treat patients with immune-related disorders, including autoimmunity, cancer, transplantation rejection, and infectious disease. They target critical immunomodulatory molecules to restore...
Strengths
- ImmuNext has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since ImmuNext was founded, the company has grown faster than the industry average
Annual Revenue
ImmuNext's annual revenue
$3912000
Based on Kona Equity data
-
Revenue per employee
$244500
-
Variance of revenue growth
0.02
-
Annual revenue growth since founding
$300923
-
Revenue growth rate from first known quarter to current
-7.1%
Employee Count
16 employees
-
Employee growth rate from first known quarter to current
-8.0%
Executives
David Delucia
CEO
d**@immunext.comSergey Seregin
Project Lead (Scientist II)
s**@immunext.comKierstin Bell
Scientist III
b**@immunext.comAleksandr Baraev
Research Associate
b**@immunext.comAnna Kuta
Scientist
k**@immunext.comMichael Molloy
Director
m**@immunext.comPhone Immunext
Chief Executive Officer
i**@immunext.comGayle Gosselin
Administrator
g**@immunext.comShibhani Rajanna
Research Associate & Scientist
r**@immunext.comDavid Driedger
IT Technician
d**@immunext.comMaria Day
Research Associate
d**@immunext.comDov Pechenick
Accounts Payable
p**@immunext.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
REGiMMUNE
regimmune.com- Founded in 2006
- Location: Berkeley, CA
- Annual Revenue: $1.9M
- Employees: 7
- REGiMMUNE is a biotech company focusing on immune regulation. With its proprietary technology, we develop therapeutics for Allergy, Transplantation, Autoimmunes REGiMMUNE is a biotechnology company producing immune regulatory therapeutics for life thre...
Bionavigen
bionavigen.com- Founded in 2018
- Location: Gaithersburg, MD
- Annual Revenue: $917.0K
- Employees: 4
- Bionavigen is a biopharmaceutical navigation company specializing in consulting for the discovery, preclinical development, translational, and regulatory sciences as well as early development of new drugs through smart acquisition. Bionavigen offers re...
Teneobio
teneobio.com- Founded in 2009
- Location: Newark, CA
- Annual Revenue: $4.0M
- Employees: 13
- TeneoBio, Inc. is a biotechnology company that is developing a new class of biologics, Human Heavy Chain Antibodies (UniAbs), as therapeutics against cancer, autoimmunity, and infectious diseases. TeneoBio has several products in pre clinical and clin...
Batu Biologics Inc
batubiologics.com- Founded in 2013
- Location: San Diego, CA
- Annual Revenue: $5.3M
- Employees: 25
- Batubiologics.com Immuno oncology firm Batu Biologics is developing universal donor therapies targeting multiple pathways to enhance efficacy & specificity of cancer treatments Batu Biologics is a preclinical biopharmaceutical company focusing on devel...
American Gene Technologies International
americangene.com- Founded in 2007
- Location: Rockville, MD
- Annual Revenue: $25.4M
- Employees: 26
- American Gene Technologies is a gene and cell therapeutics company with a proprietary lentiviral platform capable of developing cures for cancer, HIV/AIDS, and other chronic human disorders. They are currently in Phase 1 trial for an HIV cure. Their co...
BelMed
belmedny.com- Founded in 1988
- Location: New Rochelle, NY
- Annual Revenue: $2.1M
- Employees: 4
- BelMed Scientific Communications provides professional resources to pharmaceutical companies and clinical investigators. They develop publication plans to ensure accurate and timely dissemination of clinically relevant information. They also offer cons...
Key Information
- Name: ImmuNext
- Category: Pharmaceuticals
- Industry: Corporate Office
- SIC: 2834; 283
- NAICS: 32541; 3254
See similar companies
-
By City Lebanon Small Corporate Office in Lebanon Mid-size Corporate Office in Lebanon Pharmaceuticals in Lebanon Small Pharmaceuticals in Lebanon Mid-size Pharmaceuticals in Lebanon
-
By State NH Small companies in NH Pharmaceuticals in NH Small Pharmaceuticals in NH Mid-size Pharmaceuticals in NH Small Corporate Office in NH Mid-size Corporate Office in NH
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Corporate Office Small Corporate Office Mid-size Corporate Office Pharmaceuticals and Corporate Office
-
Firmographic data G Score of 6 Founded in 2011 SIC: 2834 SIC: 283 NAICS: 32541 NAICS: 3254 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare
Frequently Asked Questions
ImmuNext's headquarters are located at 1 Medical Center Dr Lebanon, NH 03756.
ImmuNext's official website is immunext.com
ImmuNext's annual revenue is $3.9 M.
ImmuNext's SIC: 2834; 283
ImmuNext's NAICS: 32541; 3254.
ImmuNext has 16 employees
ImmuNext is in the industry of Pharmaceuticals.
